Logo

Interpace Biosciences

Earnings Roundup: Lucira Health, Interpace Biosciences, Lucid Diagnostics

The diagnostics firms posted their quarterly financial results this week.

In Brief This Week: Illumina, Interpace, Genetic Signatures, Guardant Health, More

News items for the week of Aug. 29, 2022.

Earnings Roundup: Lucira Health, T2 Biosystems, Interpace Biosciences

Lucira Health, T2 Biosystems, and Interpace Biosciences reported quarterly financial results this week.

Interpace Biosciences Posts 6 Percent Revenue Increase in Q1

The company said that it experienced improved reimbursement rates and clinical services volume for its thyroid cancer tests compared to Q1 of last year.

Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx

The three companies join forces to automate sample preparation for genetic testing of endocrine and GI cancers using digital microfluidics technology.

Apr 1, 2022

Interpace Biosciences Reports 14 Percent Increase in Q4 Revenues

Feb 22, 2022

Interpace Biosciences Says CMS to Cover Thyroid Tests, Reversing Earlier Decision

Jan 31, 2022

CMS No Longer Reimbursing Interpace Bio Thyroid Tests; Firm's Rights Offering Terminated

Jan 13, 2022

Interpace Commences $30M Rights Offering

Nov 11, 2021

Interpace Biosciences Q3 Revenues Rise 15 Percent

Aug 11, 2021

Interpace Biosciences Q2 Revenues More Than Double

May 12, 2021

Interpace Biosciences Q1 Revenues Up 8 Percent

Apr 22, 2021

Interpace Biosciences to Review Strategic Alternatives

Apr 1, 2021

Interpace Biosciences Q4 Revenues More Than Double

Feb 17, 2021

Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring

Feb 1, 2021

Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker

Jan 20, 2021

Interpace Bio Q3 Revenues Rise 6 Percent

Oct 20, 2020

Interpace Biosciences Q2 Revenues Decline 14 Percent

Jun 26, 2020

Interpace Biosciences Q1 Revenues Rise 53 Percent

Apr 23, 2020

Interpace Biosciences Q4 2019 Revenues Drop 29 Percent, Miss Analyst Predictions

Jan 13, 2020

Interpace Biosciences to Sell $20M in Preferred Stock, Plans Reverse Stock Split

Jan 6, 2020

Interpace Biosciences, University of North Carolina Launch Barrett's Esophagus Study

Dec 20, 2019

Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change
Premium

Nov 13, 2019

Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences

Oct 25, 2019

Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.